Skip to content
10-Q

Quarterly Report

LIPOSCIENCE INC

0001168197-13-000051

← back to feed
Filed
Nov 8, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 5, 2013 15.16M sh
Shares Diluted Q3 2013 · Sep 30, 2013 14.73M sh
Shares Diluted Q3 2013 · Sep 30, 2013 14.73M sh
Shares Diluted Q3 2013 · Sep 30, 2012 1.7M sh
Shares Diluted Q3 2013 · Sep 30, 2012 3.15M sh
Long Term Debt Q3 2013 · Sep 30, 2013 $11.88M
Long Term Debt Q3 2013 · Dec 31, 2012 $15.71M
Short Term Debt Q3 2013 · Sep 30, 2013 $3.9M
Short Term Debt Q3 2013 · Dec 31, 2012 $0
Stockholders Equity Q3 2013 · Sep 30, 2013 $49.11M
Stockholders Equity Q3 2013 · Dec 31, 2012 −$39.56M
Current Liabilities Q3 2013 · Sep 30, 2013 $9.53M
Current Liabilities Q3 2013 · Dec 31, 2012 $11.35M
Total Liabilities Q3 2013 · Sep 30, 2013 $24.05M
Total Liabilities Q3 2013 · Dec 31, 2012 $29.93M
Current Assets Q3 2013 · Sep 30, 2013 $59.18M
Current Assets Q3 2013 · Dec 31, 2012 $30.76M
Total Assets Q3 2013 · Sep 30, 2013 $73.16M
Total Assets Q3 2013 · Dec 31, 2012 $47.68M
Eps Diluted Q3 2013 · Sep 30, 2013 −$0.31
Eps Diluted Q3 2013 · Sep 30, 2013 −$0.67
Eps Diluted Q3 2013 · Sep 30, 2012 −$0.28
Eps Diluted Q3 2013 · Sep 30, 2012 $0.10
Eps Basic Q3 2013 · Sep 30, 2013 −$0.31
Eps Basic Q3 2013 · Sep 30, 2013 −$0.67
Eps Basic Q3 2013 · Sep 30, 2012 −$0.28
Eps Basic Q3 2013 · Sep 30, 2012 $0.12
Capex Q3 2013 · Sep 30, 2012 $5.73M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $10.28M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $12.48M
Sga Expense Q3 2013 · Sep 30, 2012 $2.71M
Sga Expense Q3 2013 · Sep 30, 2012 $7.76M
Rd Expense Q3 2013 · Sep 30, 2012 $2.53M
Rd Expense Q3 2013 · Sep 30, 2012 $7.45M
Net Income Q3 2013 · Sep 30, 2012 −$481K
Net Income Q3 2013 · Sep 30, 2012 $1.06M
Operating Income Q3 2013 · Sep 30, 2012 −$214K
Operating Income Q3 2013 · Sep 30, 2012 $1.66M
Gross Profit Q3 2013 · Sep 30, 2012 $10.94M
Gross Profit Q3 2013 · Sep 30, 2012 $33.62M